MARKET

CLDI

CLDI

Calidi Biotherapeutics Inc
AMEX
1.180
+0.010
+0.85%
After Hours: 1.210 +0.03 +2.54% 19:52 01/02 EST
OPEN
1.150
PREV CLOSE
1.170
HIGH
1.220
LOW
1.150
VOLUME
35.49K
TURNOVER
--
52 WEEK HIGH
19.20
52 WEEK LOW
1.100
MARKET CAP
8.46M
P/E (TTM)
-0.1227
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CLDI last week (1222-1226)?
Weekly Report · 12/29/2025 09:51
Weekly Report: what happened at CLDI last week (1215-1219)?
Weekly Report · 12/22/2025 09:51
Weekly Report: what happened at CLDI last week (1208-1212)?
Weekly Report · 12/15/2025 09:56
Weekly Report: what happened at CLDI last week (1201-1205)?
Weekly Report · 12/08/2025 09:55
Weekly Report: what happened at CLDI last week (1124-1128)?
Weekly Report · 12/01/2025 09:53
Weekly Report: what happened at CLDI last week (1117-1121)?
Weekly Report · 11/24/2025 09:56
Weekly Report: what happened at CLDI last week (1110-1114)?
Weekly Report · 11/17/2025 09:56
Calidi Biotherapeutics GAAP EPS of -$2.21 misses by $0.53
Seeking Alpha · 11/13/2025 22:44
More
About CLDI
Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company. The Company is developing proprietary allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses (vaccinia virus and adenovirus) and, potentially, other molecules to cancer patients. It is focused on developing two proprietary stem cell-based platforms and one enveloped vaccinia virus platform designed to protect the oncolytic virus, whether natural or engineered, from neutralization by the patient’s immune defenses, allowing for greater infection of the tumor cells and leading to a potential improvement in the antitumor activity of oncolytic viruses over traditional naked oncolytic virus therapies. Its product candidates include the CLD-101 product for high grade glioma (HGG), CLD-101 product for Recurrent HGG, CLD-201 product for solid tumors, CLD-301 (AAA) for multiple indications and CLD-400 (RTNova) for certain lung cancer and metastatic solid tumors.

Webull offers Calidi Biotherapeutics Inc stock information, including AMEX: CLDI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLDI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLDI stock methods without spending real money on the virtual paper trading platform.